BackHeat Biologics Overview

Heat Biologics Current Cash

Latest current cash for HTBX: $580B.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$581.61B

Peer trimmed avg / median

Loading

Heat Biologics Current Cash History

Loading

Heat Biologics vs. peers: Current Cash Comparison

Loading

Heat Biologics Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Heat Biologics (HTBX) FAQ

Heat Biologics (HTBX) currently reports a current cash of $580B as of September 2025. Use the charts on this page to explore Heat Biologics's current cash history and peer comparisons.

Heat Biologics reported $580B in current cash as of September 2025. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $580B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Heat Biologics, and consider following HTBX for alerts when major investors trade the stock.

Heat Biologics is classified in the Healthcare sector. On current cash, it currently shows $580B. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing HTBX with unrelated industries.